chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 100.8 x 30 hours chills headache in nape of neck. unsteady arm soreness weak no sleep little appetite felt very very bad after 2nd dose on April 27. Awoke sweating profusely bed damp pajamas damn at 6:30 on Thursday, April 29 to loud ringing buzzing whining in both ears. Pressure in ears soreness in ears deep where ears meet brain. Feels as if ears will burst if I lean over. Headache in forehead. Fever 99.0 -99.4.  Ear pressure aching ringing has continued since. At times, left ear feels like a void like I can?t hear. Right ear like it hears too well too loud. Music songs sound different. Like not blended. Like missing a part. When 2 many sounds happening, I can?t distinguish detail. It?s all blurred. An ambulance went by. I couldn?t hear with my left ear. Seatbelt beeping in car is faint and does not bother me now.
2-3 day h/o of rash on trunk and face. On exam + vesicular lesions scattered on trunk and few on face, no signs of infection.
his arm looked like he had a baseball/Swollen/huge; Itching; hard as a rock; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE SWELLING (his arm looked like he had a baseball/Swollen/huge), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE INDURATION (hard as a rock) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (his arm looked like he had a baseball/Swollen/huge), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE INDURATION (hard as a rock). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE SWELLING (his arm looked like he had a baseball/Swollen/huge), VACCINATION SITE PRURITUS (Itching) and VACCINATION SITE INDURATION (hard as a rock) had resolved.            No concomitant medications reported.
This spontaneous report was received from a physician via an unspecified reporter referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 23-MAR-2016, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 PK 0.5mL SD-PFS LLokwTip 10PK" and lot number L014876 with expiration date of 13-JAN-2017 (route of administration and anatomical location were not reported), which was stored at a lowest recorded temperature of 27F (-2.777777778 Celsius) for 1764 hours. The vaccine status was reported as excursion and the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
no other AE occurred; an expired dose was administered to the patient; This spontaneous report was received from a licensed practical nurse referring to a patient of unspecified age or gender. The patient's concurrent conditions, concomitant medications, pertinent medical history, drug reactions or allergies were not informed.   On 15-MAY-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status recombinant human albumin (rHA)) (M-M-R II) injection (1 dosage form (1 dose), lot# U014655, expiration date 07-MAY-2023, strength, route and anatomical location were unknown) for prophylaxis (expired product administered). No other adverse event was occurred (no adverse event), and the product did not have any temperature excursions prior to administration.
6 days after MMR, pt developed fever, cough, hive like rash. BENADRYL given. Strep R/O. Then rash continued to spread over body by day 9, change in color (red/white/blue) and feet swelled. Antihistamine given more routinely. Diagnosed with erythema multiforme.
Red area with heat and welt day after shots give and at 24 hours 15cm x 15cm. Given KEFLEX 500mg QID x 10 days. Four hours later sent to ED for cellulitis.
104 fev x 48 hours after immunizations. * Mom just told us about reaction today*.
The patient is 17 years old and was given a 3rd dose of Pfizer vaccine when the booster is only indicated for 18 years and up.
pt recv vax APR94; pt was noted that this did not make urticaria any worse; however, the urticaria persisted another 2 wk;
The day following the vaccination patient had flu-like symptoms, felt achey and fatigued. This was followed by the area around the vaccination becoming hard to the touch and the following day when seen in the clinic the arm was swollen and tender to palpation.
Slight headache, fatigue/muscle aches, intense pain in the arm at injection site beginning 02/05/22 (next morning) when waking up.  Headache, fatigue/muscle aches resolved with Tylenol (acetaminophen) and were gone by the late evening on 02/05/22 (a bit over 24 hours after dose).  Heart palpitations and pressure in the chest beginning late morning/early afternoon on 02/05/22. Pressure in chest resolved by the morning of 02/08/22.  Intense nerve pain on the clavicle to shoulder at injection site beginning morning of 02/06/22 and resolving the evening of 02/08/22.  Pain in shoulder/arm moving down to fingers in left arm beginning 02/08/22 and resolving 02/11/22.  Heart palpitations have not resolved. They are sporadic, intense and inconsistent (does not matter what activity is being done).
Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. No Medical History information was reported.On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster/ wrong dose for Bivalent Vaccine booster dose (underdose). No AEs were reported). No concomitant product reported by reporter. It was reported that 100 patients were administered an invalid dose of Moderna COVID-19 bivalent booster. The nurse had no standing order other than what they had for second booster, when administering bivalent boosters, so they assumed same dose as second booster and administered 0.25mL to uncompromised adults. This case was for one of the patient among the 100 patients who were administered an invalid dose of Moderna COVID-19 bivalent booster.   It was reported that CDC had recommended to revaccinate the patients with full dose of 0.5mL.  No treatment medication reported by reporter.
I had my 2nd shot on 3/25/21. Two weeks to the day I had a severe dizzy episode, abnormally talking out of head, confused, sweating. Exactly two weeks later from that( 1 month from vaccine) had the same episode, hands and feet went numb. Extremely confused,  extremely dizzy, no prior health conditions. Doctor has said it is severe vertigo. Further treatment and now I?m waiting to see a neurologist due to the severity of the reaction
Patient reports reddish, pink spots appeared on her left arm the day after her injection. One spot around injection site, one down by her forearm, and one near the wrist. The spots became very itchy, then turned into blisters that lasted for 2 weeks after injection. She reports a fever of 101 degrees F off an on throughout the 2 weeks after injection. Additional pink spots appeared bilaterally on her arms, legs, stomach, and breasts. She estimates during the 2 week period post-vaccination she had about 20 spots that turned into blisters. All were extremely itchy, but otherwise not problematic.
"out of body" sensation apparently 5 min after vaccination. Lasted 2-3 min then back to normal.
9/16/16-1st rabies vaccine -> did ok. 9/23/16-pt given 2nd rabies vaccine -> rash around site-maculopapular. Cleared in a few days. 10/7/16-pt given 3rd rabies vaccine-localized RUE maculopapular rash. (-) angioedema.
Tightness; Muscle Pain in the injection site of the right arm; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the right arm on 30Apr2021 at 15:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, perimenopause, menorrhagia and COVID-19. The patient did not have any known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included biotin (MANUFACTURER UNKNOWN) and women's multivitamin (MANUFACTURER UNKNOWN); both started from an unknown date, for an unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. On 01May2021 at 00:00, the patient experienced tightness and muscle pain in the injection site of the right arm. Therapeutic measure was taken as a result of tightness and muscle pain in the injection site of the right arm which included treatment with ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, tightness and muscle pain in the injection site of the right arm was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Presented to ED c/o fever s/p COVID-19 vaccination onset today.  Received vaccine at 12 pm today and started experiencing chills around 8 pm today with continued progression in intensity.  Patient received 2 doses of Benadryl PTA without relief.  Patient experienced a seizure while in triage at 2135 and recorded temperature was 102.8 F.  Temperature PTA 103.8.  Patient had no more seizures and was treated and released.
Rash appeared below injection site on 2/1/21. Area red and itchy.  Looked like COVID arm rash pictured on internet.  Rash gone by 2/10/21.
No Adverse Event; Moderna Bivalent vaccine was administered Beyond use by date to 6 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered Beyond use by date to 6 patients) and NO ADVERSE EVENT (No Adverse Event) in a 24-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 042H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 08-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered Beyond use by date to 6 patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered Beyond use by date to 6 patients) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered Beyond use by date to 6 patients).    No concomitant medication was provided by reporter. No treatment medication was provided by reporter.
Acute Renal Failure, Azotemia, Elevated calcium level, Weakness - ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
patient complains that she feels dizzy. no chest pain or sob. no nausea or vomiting. no sensation of fainting.
Left arm localized reaction. Swelling approx 4.5cm. Warmth and intensely pruritic at site. Minimal erythema.
6 1/2 x 5 1/2cm area of redness, warmth & raised;
Substantial pain at injection site; headache; neck pain; lower back pain; chills; fever; dizzy; 24 hours of grief; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Oct2021 (Batch/Lot number: unknown) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), for Covid-19 immunization; Bnt162b2 (Dose:2), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 06Oct2021, outcome "recovering", described as "Substantial pain at injection site"; HEADACHE (non-serious) with onset 06Oct2021, outcome "recovering", described as "headache"; NECK PAIN (non-serious) with onset 06Oct2021, outcome "recovering", described as "neck pain"; BACK PAIN (non-serious) with onset 06Oct2021, outcome "recovering", described as "lower back pain"; CHILLS (non-serious) with onset 06Oct2021, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 06Oct2021, outcome "recovering", described as "fever"; DIZZINESS (non-serious) with onset 06Oct2021, outcome "recovering", described as "dizzy"; GRIEF REACTION (non-serious) with onset 06Oct2021, outcome "recovering", described as "24 hours of grief". Therapeutic measures were not taken as a result of vaccination site pain, headache, neck pain, back pain, chills, pyrexia, dizziness, grief reaction.  Additional information included: It was significant enough to make wonder if contacting COVID would be less impactful. It was reported that batch/lot number was unavailable at the time of report completion. Patient did not received any other vaccine within 4 weeks prior to the COVID vaccine. Patient did not received any other medications within 2 weeks of vaccination. Prior vaccination patient was not diagnosed with COVID-19. Since the vaccination patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
feeling nauseated; she can't eat anything; she threw up; A spontaneous report () was received from a consumer concerning a 75-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events feeling nauseated, she can't eat anything, she threw up.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Not available) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) feeling nauseated, she can't eat anything, she threw up.  Treatment details included Promethazine 0.5mg.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), feeling nauseated, she can't eat anything, she threw up was unknown.
Patient experienced weakness of legs and knees especially R leg.   He felt like he had to drag his leg. Some wekaness and numbness of R leg. Denies weakness of arms.
12/9/21 - MILD cold with runny nose and scratchy throat.  Did not impact ability to work or complete ADLs.   12/19/21 - fever 12/20/21 - shortness of breath and fever which prompted visit to PCP.  Chest XR showed pneumonia, likely viral in nature.  Sats were 92 on the PCP office 12/21/21 - sats in the 80s all day, went to ER.  Chest XR showed pneumonia, admitted, antibiotics started 12/25/21 - condition worsened and ultimately intubated until 12/31, received numerous antibiotics and high dose steroids.  Received Tocilizumab and responded to this medication, ALL labs/cultures (histo, toxo, MRSA....and many many others, including COVID 2 rapids, 3-4 PCRs, 2 IgG antibodies titers) were negative.  Bilateral pulmonary emboli discovered on CT.  Pneumothorax small bilateral at apex.   12/31/21 - extubated  1/13/22 - large pneumothorax in left lung which ultimately required 3 chest tubes 1/17/22 - surgery which showed lung fibrosis, organizing pneumonia and empyema.  Numerous antibiotics started.  Reintubated.   2/22 - trach and PEG tub inserted 2/9/22 - transferred to Facility 2/29/22 - transferred to acute rehab  3/12/22 - finally by the power of Jesus Christ he came home!   WE STILL HAVE NO ANSWER FOR WHY THIS OCCURED!  He was healthy prior to this event.  No co-morbidities.  We are NOT anti-COVID vaccine and willingly and readily received our doses; however,  we believe it is prudent to share what occured.
Experienced 36 sleep apnea episodes an hour; This is a spontaneous report based on the information received by Pfizer from Medical Information (Case ID: GI-2019-9828). The contactable consumer reported for herself. A 69-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced 36 sleep apnea episodes an hour on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
nausea, dizziness, fogginess, uncontrolled trembling, high blood pressure, anxiety, headaches, body aches, generalized unwell feeling, weight loss, shortness of breath on and off for the passed 7 months and counting.  multiple doctor visits, er visits, and specialists visits. almost $2000 in medical debt. Multiple labs, x-rays, CT scans, mri, pft, ekg, Ultrasound, Echo, and medications. Missed numerous days of work and important events from being sick. My life has been turned upside down since receiving this vaccine.
Weakness; Body Aches; Headaches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), MYALGIA (Body Aches), HEADACHE (Headaches) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 04-Feb-2021, the patient experienced ASTHENIA (Weakness), MYALGIA (Body Aches), HEADACHE (Headaches) and CHILLS (Chills). At the time of the report, ASTHENIA (Weakness), MYALGIA (Body Aches), HEADACHE (Headaches) and CHILLS (Chills) outcome was unknown.            no concomitants were reported no treatment medications were reported.   Reporter did not allow further contact
Since my daughter had received this twice before. State law says she has to have the shots MMR and DTP at a later date.  This was the third time my daughter has received those shots.  She has been exhibiting signs of adhd since.
Extremely sore L arm next day, difficult to raise arm because of pain, and gradually less sore over the course of a full week. Tired and fluish feeling, general muscle aches with daily temps over 100 for 3 days. Medicated myself with Tylenol.
Patient presents in the area of injection "rash", rash, and itching. In addition to common adverse effects such as redness, pain, hardening and inflammation. Patient showed up at the pharmacy on Saturday, June 11, 2022 to notify. He was guided on common adverse effects and instructed to remain symptomatic by Monday to visit his preferred doctor. Report Monday 13 June 3:25pm
Assessment and Plan:      1. Elevated temperature Active   2. Local reaction to COVID-19 vaccine Active      Plan: Madura no vaccine administered yesterday.  Patient woke this morning with fatigue and malaise, as well as elevated temperature and elevated heart rate.  Patient has been reassured that the symptoms she is currently experiencing are normal for the Covid vaccine and will pass within 24 to 48 hours.  Patient feels reassured and has expressed understanding.  She is encouraged to continue to hydrate well and use ibuprofen as needed for discomfort. Follow-up: No follow-up provider specified. Subjective: Patient ID:   a 36 y.o. female who presents today with a chief complaint of: No chief complaint on file. 36-year-old female patient presents to express care crying with concerns about an elevated heart rate and temperature after receiving the Covid vaccine yesterday.  Patient is very concerned that her heart rate may mean "something is wrong with her heart." HPI ROS Patient Reported Taking    No current medications.
She started crying while sleeping and for the last three days she is waking up crying at night. She says her mouth and throat hurts.
Headache, exhaustion, extreme arm pain, extreme joint pain, muscle aches, arm bruising, nausea, fever, chills
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drugs were provided.
Mother called 12/22/09 to report child had seizure at home on Nov 1, 2009. Was seen at hosp ER. No fever with H1N1 FLUMIST reported. Followed up with pediatrician had another seizure Dec 1, 2009 @ school, seen by pediatric neurologist Dec 15, 2009. Started on meds, seized again 12/20/09.